170 related articles for article (PubMed ID: 25691629)
1. Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae.
Cannatelli A; Santos-Lopez A; Giani T; Gonzalez-Zorn B; Rossolini GM
Antimicrob Agents Chemother; 2015 May; 59(5):2898-900. PubMed ID: 25691629
[TBL] [Abstract][Full Text] [Related]
2. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.
Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P
J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Amino Acid Substitution W20S in MgrB Involved in Polymyxin Resistance in Klebsiella pneumoniae.
Roch M; Martins WMBS; Sierra R; Gales AC; Andrey DO
Microbiol Spectr; 2022 Feb; 10(1):e0176621. PubMed ID: 35171013
[TBL] [Abstract][Full Text] [Related]
4. Induction and nosocomial dissemination of carbapenem and polymyxin-resistant Klebsiella pneumoniae.
Gaspar GG; Bellissimo-Rodrigues F; Andrade LN; Darini AL; Martinez R
Rev Soc Bras Med Trop; 2015; 48(4):483-7. PubMed ID: 26132495
[TBL] [Abstract][Full Text] [Related]
5. Molecular and epidemiological surveillance of polymyxin-resistant Klebsiella pneumoniae strains isolated from Brazil with multiple mgrB gene mutations.
da Silva KE; Thi Nguyen TN; Boinett CJ; Baker S; Simionatto S
Int J Med Microbiol; 2020 Oct; 310(7):151448. PubMed ID: 33092694
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.
Zhu Y; Galani I; Karaiskos I; Lu J; Aye SM; Huang J; Yu HH; Velkov T; Giamarellou H; Li J
J Infect; 2019 Oct; 79(4):312-321. PubMed ID: 31374222
[TBL] [Abstract][Full Text] [Related]
7. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
[TBL] [Abstract][Full Text] [Related]
8. A
Kidd TJ; Mills G; Sá-Pessoa J; Dumigan A; Frank CG; Insua JL; Ingram R; Hobley L; Bengoechea JA
EMBO Mol Med; 2017 Apr; 9(4):430-447. PubMed ID: 28202493
[No Abstract] [Full Text] [Related]
9. Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae.
Pitt ME; Elliott AG; Cao MD; Ganesamoorthy D; Karaiskos I; Giamarellou H; Abboud CS; Blaskovich MAT; Cooper MA; Coin LJM
Microb Genom; 2018 Mar; 4(3):. PubMed ID: 29431605
[TBL] [Abstract][Full Text] [Related]
10. Media for colistin susceptibility testing does not improve the detection of Klebsiella pneumoniae isolates carrying MgrB disruption and other mutation driven colistin resistance mechanisms.
Castanheira M; Doyle TB; Carvalhaes CG; Roth BM; Rhomberg PR; Mendes RE
Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115077. PubMed ID: 32629337
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
Kim SY; Shin J; Shin SY; Ko KS
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
[TBL] [Abstract][Full Text] [Related]
12. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India.
Kumar A; Biswas L; Omgy N; Mohan K; Vinod V; Sajeev A; Nair P; Singh S; Biswas R
Rev Esp Quimioter; 2018 Oct; 31(5):406-410. PubMed ID: 30221899
[TBL] [Abstract][Full Text] [Related]
13. mcr-1 Gene Has No Effect on Colistin Resistance When It Coexists with Inactivated mgrB Gene in Klebsiella pneumoniae.
Zhang H; Zhao D; Shi Q; Quan J; Li X; Yu Y
Microb Drug Resist; 2018 Oct; 24(8):1117-1120. PubMed ID: 29768099
[TBL] [Abstract][Full Text] [Related]
14. Genotyping of paired KPC-producing Klebsiella pneumoniae isolates with and without divergent polymyxin B susceptibility profiles.
Sampaio SCF; Bigelli Carvalho RL; Mimica MJ; da Silva CB; Mimica LMJ; de Lima AV; Lima KO; Rocha DADC; Sampaio JLM
Braz J Microbiol; 2021 Dec; 52(4):1981-1989. PubMed ID: 34460074
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors.
Llobet E; Campos MA; Giménez P; Moranta D; Bengoechea JA
Infect Immun; 2011 Sep; 79(9):3718-32. PubMed ID: 21708987
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
[TBL] [Abstract][Full Text] [Related]
17. mgrB Mutations Mediating Polymyxin B Resistance in Klebsiella pneumoniae Isolates from Rectal Surveillance Swabs in Brazil.
Aires CA; Pereira PS; Asensi MD; Carvalho-Assef AP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6969-6972. PubMed ID: 27620478
[TBL] [Abstract][Full Text] [Related]
18. Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca.
Jayol A; Poirel L; Villegas MV; Nordmann P
Int J Antimicrob Agents; 2015 Jul; 46(1):108-10. PubMed ID: 25982250
[TBL] [Abstract][Full Text] [Related]
19. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature.
Elemam A; Rahimian J; Mandell W
Clin Infect Dis; 2009 Jul; 49(2):271-4. PubMed ID: 19527172
[TBL] [Abstract][Full Text] [Related]
20. A new mutation in mgrb mediating polymyxin resistance in Klebsiella variicola.
Lenzi MH; Martins WM; Roch M; Ramos PL; Sands K; Cayô R; Walsh TR; Andrey DO; Gales AC
Int J Antimicrob Agents; 2021 Nov; 58(5):106424. PubMed ID: 34419577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
